AstraZeneca pharmaceutical products

AstraZeneca is one of the world's leading science-led biopharmaceutical companies, specializing in the discovery, development, and commercialization of prescription medicines in areas such as Oncology, Cardiovascular, and Respiratory health. The brand became globally recognized for its significant role in vaccine development during the 2020s COVID-19 pandemic.

The brand was formed through a major strategic merger in 1999, bringing together deep-rooted scientific heritages from both Sweden and the United Kingdom. Today, its operations are highly globalized, with a presence in over 100 countries. Because of its massive scale, manufacturing is distributed across a worldwide network of facilities, including major production hubs in Sweden, the United Kingdom, the United States, China, and India, ensuring a resilient supply chain for critical medications.

As a publicly traded entity, AstraZeneca PLC is owned by institutional and individual investors rather than a single parent corporation. It maintains its global corporate headquarters in Cambridge, United Kingdom, which serves as a central hub for its research and development initiatives. The company continues to operate as an independent powerhouse in the global healthcare market, focused on delivering innovative treatments for some of the world's most complex diseases.